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Abstract
Rationale The startle reflex to a sudden intense acoustic
pulse stimulus is attenuated if the pulse is shortly preceded
by a weak prepulse stimulus. This represents a form of
sensory gating, known as prepulse inhibition (PPI), observ-
able across species. PPI is modulated by dopamine and
readily disrupted by acute amphetamine. Prior repeated
exposures to amphetamine also disrupt PPI even when the
drug is not present during test, suggesting that a sensitized
mesolimbic dopamine system—inducible even by a single
exposure to amphetamine—might be responsible. However,
this causative link has been challenged by inconsistent effi-
cacy between different amphetamine pre-treatment regimes,
which all robustly sensitize the behavioral response to
amphetamine.
Methods Here, the presence of such a link in reverse was
tested by comparing the propensity to develop amphetamine
sensitization between high- and low-PPI expressing individ-
uals identified within a homogeneous cohort of C57BL/6
mice. Comparison of dopamine content including its metab-
olites was performed separately in drug naïve mice by post-
mortem HPLC.
Results Behavioral sensitization was substantially stronger
in the low-PPI group compared with the high-PPI group,
while the magnitude of their response to the first amphet-
amine challenge was similar. Dopamine content within the
nucleus accumbens and medial prefrontal cortex was signif-
icantly higher in low-PPI relative to high-PPI mice.
Conclusion Individuals with weak sensory gating character-
ized by low basal PPI expression may be more susceptible
to the development of dopamine sensitization and therefore
at greater risk of developing schizophrenia. Conversely,
high baseline expression might predict a resistance to dopa-
minergic sensitization.
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Introduction
Dopaminergic dysfunction remains a central pathophysiolog-
ical theory of schizophrenia (Carlsson 1988; Howes and
Kapur 2009; Howes et al. 2012). One theory suggests that
the underlying hyperdopaminergia in schizophrenia is func-
tionally similar to that of a sensitized dopaminergic state
(Laruelle 2000). This can be induced in animals by prior
exposure to psychostimulant drugs such as amphetamine or
cocaine, which acts as an indirect dopamine receptor agonist
(Pierce and Kalivas 1997; Robinson and Becker 1986). A
single exposure to amphetamine is sufficient to substantially
enhance the acute response to a subsequent drug challenge
(Robinson and Becker 1986). The neuroplastic changes re-
sponsible for amphetamine sensitization have been studied
using withdrawal models in the absence of any acute drug
effect (Murphy et al. 2001; Peleg-Raibstein and Feldon 2008;
Peleg-Raibstein et al. 2006a, b, c, 2008, 2009; Russig et al.
2005; for a review see Featherstone et al. 2007). Regarding the
face validity of such amphetamine withdrawal models, one
outstanding debate focuses on their reliability in capturing the
sensorimotor gating deficits in schizophrenia (Featherstone et
al. 2007; Peleg-Raibstein et al. 2006a; Russig et al. 2005)
because such perceptual gating impairments are believed to
yield sensory flooding and cognitive fragmentation that con-
tribute to the psychotic experience and cognitive symptoms of
schizophrenia (Braff and Geyer 1990; Swerdlow et al. 1994).
Sensorimotor gating in animals and human can be effec-
tively assessed by the cross-species paradigm of prepulse
inhibition (PPI) of the acoustic startle reflex (Braff et al.
1992, 2001; Swerdlow et al. 2001). PPI is demonstrated as
the attenuation of the startle response to a sudden and intense
startle-eliciting “pulse” stimulus when it is shortly preceded
by a non-startling “prepulse” stimulus of considerably lower
intensity. Perception of the prepulse is supposed to gate or
inhibit the processing of the succeeding pulse stimulus, lead-
ing to a weaker response to the latter (Graham 1975). Defi-
ciency in this fundamental form of sensory gating is
frequently observed in schizophrenia patients (Braff et al.
1992, 2001), although it has also been reported in patients
with obsessive-compulsive disorder, Parkinson's disease, and
Huntington's disease (Abbruzzese and Berardelli 2003;
Ahmari et al. 2012; Valls-Solé et al. 2004). Reports of similar
deficiency in non-symptomatic relatives of schizophrenia
patients further led to the suggestion that PPI deficiency
represents an endophenotype of schizophrenia (Braff 2010).
Healthy individuals in the general population scoring high on
schizotypy personality scale are also associated with weaker
PPI (Cadenhead et al. 2000).
Various experimentally induced PPI deficits have been
considered as models of schizophrenia-related sensorimotor
impairment (Geyer et al. 2001), but the expected link be-
tween amphetamine withdrawal and PPI deficiency seems to
be critically dependent on the precise regimes of amphet-
amine exposures, even though they are all effective in
potentiating the motor response to a subsequent amphet-
amine challenge (Murphy et al. 2001; Peleg-Raibstein et
al. 2006a, b, c, 2008, 2009; Russig et al. 2005).
The present study undertook a fresh approach to examine
this apparently elusive link. Instead of focusing on the hy-
pothesized causal relationship between prior amphetamine
exposures and subsequent sensorimotor gating deficiency,
the present study evaluated whether individual differences in
baseline sensorimotor gating function might predict the pro-
pensity to develop amphetamine sensitization. Subjects with
low baseline levels of PPI were expected to be more vulner-
able or responsive to the development of amphetamine sensi-
tization, whereas subjects with high baseline PPI might even
confer resistance. This experiment thus provides the first test
of whether baseline PPI measures can predict an important
form of dopaminergic plasticity central to schizophrenia path-
ophysiology. The outcome would be relevant to the possible
use of PPI to identify individuals with higher risk for devel-
oping psychosis, and the contribution of environmental fac-
tors, such as stress, that are known to modulate the
development of dopaminergic sensitization.
Here, a homogeneous cohort of naïve wild-type mice was
screened by a standard PPI procedure to identify the upper
(high-PPI) and lower (low-PPI) third individuals. To avoid
the complication concerning different amphetamine with-
drawal regimes, we employed the simplest procedure with
a single amphetamine pre-exposure. The motor response to
the first and second challenge of amphetamine (2.5 mg/kg,
i.p.), separated by 5 days, was monitored in an open field.
Post-mortem neurochemical analysis of dopamine and its
metabolites in the brain was carried out in a separate cohort
of mice having undergone a similar PPI screening. The
high-PPI and low-PPI mice identified from this cohort all
remained completely drug naïve until sacrifice. This further
allowed us to examine if such divergence in baseline PPI
might already be differentiated by markers for intrinsic
dopaminergic functions.
Material and methods
Subjects
Two independent cohorts of 12-week-old male C57BL/
6NCrl mice were used. They were bred in the Laboratory
of Behavioural Neurobiology (Swiss Federal Institute of
Technology Zurich) from C57BL/6NCrl (strain code 027)
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breeding pairs originating from Charles River (Germany).
The first cohort comprised 23 mice, out of which seven
“high-PPI” and seven “low-PPI” subjects were identified.
The second cohort comprised 100 mice, out of which the
brains of 15 “high-PPI” and 13 “low-PPI” subjects were
used in the post-mortem analysis of dopaminergic metabo-
lites here. All mice were housed individually with ad libitum
access to food and water, in a temperature- and humidity-
controlled (22±1 °C, 55±5 %) vivarium maintained under a
reversed 12/12 h light–dark cycle (lights on 1900–0700 h).
All behavioral evaluations were conducted during the dark
phase of the cycle. All procedures were conducted in accor-
dance with the National Institutes of Health Guide for Care
and Use of Laboratory Animals (1996) and had been ap-
proved by the Cantonal Veterinarian’s Office of Zurich.
Prepulse inhibition of the acoustic startle reflex
Prepulse inhibition (PPI) of the acoustic startle reflex (ASR)
was assessed using four identical acoustic startle chambers
for mice (SR-LAB; San Diego Instruments, San Diego, CA,
USA). Each chamber comprised a non-restrictive Plexiglas
cylindrical enclosure attached horizontally on a mobile plat-
form, which was in turn resting on a solid base inside a
sound-attenuated isolation cubicle. A high-frequency loud-
speaker mounted directly above the animal enclosure inside
each cubicle produced a continuous background noise of
65 dBA and the various acoustic stimuli in the form of white
noise. Vibrations of the Plexiglas enclosure caused by the
whole-body motion of the animal were converted into ana-
logue signals by a piezoelectric unit attached to the plat-
form. These signals were digitized and stored by a
computer. In total, 130 consecutive readings were taken at
0.5-ms intervals (i.e., spanning across a 65-ms response
window), starting at the onset of the startle stimulus in
pulse-alone and prepulse-plus-pulse trials, and at the onset of
the prepulse stimulus in prepulse-alone trials. The average
amplitude over the 65-ms window was used to determine
the stimulus reactivity. The sensitivity of the stabilimeter
was calibrated daily to ensure consistency between chambers
and across sessions.
The pulse stimulus employed was 120 dBA in intensity
and 40 ms in duration. Prepulses of various intensities were
employed: 69, 73, 77, 81, and 85 dBA, which corresponded
to 4, 8, 12, 16, and 20 dBA above background noise,
respectively. The duration of prepulse stimuli was 20 ms.
The stimulus onset asynchrony of the prepulse and pulse
stimuli on prepulse-plus-pulse trials was 100 ms.
After being placed into the Plexiglas enclosure, the animals
were acclimatized to the apparatus for 2 min before the first
trial began. The 35-min-long test session began with six trials
consisted of pulse-alone trials, which served to habituate and
stabilize the animals' startle response. Subsequently, the
animals were presented with 12 blocks of discrete test trials.
Each block consisted of one trial of each of the following trial
types: pulse-alone, prepulse-plus-pulse trials of each of the
five levels of prepulse, prepulse-alone of each of the five
levels of prepulse, and no stimulus (i.e., background noise
alone). The session was concluded with the final set of six
consecutive startle-alone trials. The interval between succes-
sive trials was variable with a mean of 15 s (ranging from 10 to
20 s). Four animals were tested at a time, and the apparatus
was cleansed before the next four animals were tested.
The reduction of startle magnitude in prepulse-plus-pulse
trials relative to those in pulse-alone trials constitutes PPI.
Percentage PPI was computed as follow: [startle reactivity in
the pulse alone trial−startle reactivity in the prepulse and
pulse trial]/[startle reactivity in the pulse alone trial]×100 %.
Amphetamine sensitization and open field locomotor
activity
The motor stimulant effect of amphetamine was assessed
using eight identical open field arenas made of acrylic plastic,
each measuring 40×40 cm in surface area and surrounded on
all sides by a 30-cm-highwall. They were placed in the middle
of two testing rooms, each housing four open fields, with
diffused lighting (15 lx). The arenas were positioned directly
under a digital camera transmitting images to a PC running the
Ethovision tracking software (Noldus Technology, The Neth-
erlands) at a rate of five frames per second. Locomotor activity
was indexed by the cumulative displacement of the center of
gravity of the subject's surface area over successive frames in
successive 5-min bins.
The open field test consisted of three phases. First, the
animals were gently placed in the center of an arena and left
undisturbed for 15 min to measure baseline locomotor activity
(baseline phase). Next, they were then injected with physio-
logical saline (0.9 % NaCl) and returned to the arena for
another 15 min (saline phase). Next, the animals were injected
with amphetamine (2.5 mg/kg) and observed for 2 h in the
same arena (amphetamine phase). Afterwards, they were
returned to the home cage; the arenas were cleansed with
5 % ethanol and air-dried prior to testing of the next squad.
All solutions for injection were freshly prepared on the day.
D-Amphetamine (in the form of D-amphetamine hemi-
sulfate) was obtained from Sigma-Aldrich (Switzerland).
Then 0.5 mg of D-amphetamine hemisulfate was dissolved
in every milliliter of sterile physiological saline (0.9 %
NaCl), and the solution was injected at a volume/body
weight ratio of 5 ml/kg via the intraperitoneal route. All
animals underwent two consecutive amphetamine challenge
administrations separated by 5 days, when the animals
remained undisturbed in their home cage. Behavioral sensi-
tization to amphetamine was assessed within-subject by
comparing the reaction to the drug in the two tests.
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Segregation of high and low baseline PPI subjects
Based on their initial PPI screening results, the cohort of 23
mice were ranked according to their individual average
%PPI values. Animals with the seven highest and the seven
lowest mean %PPI scores were designated as "high-PPI"
and "low-PPI" subjects, respectively, and were used in the
amphetamine sensitization experiment. No further criteria of
segregation were necessary as this did not yield any differ-
ence in startle reactivity as such (see full description in
“Results” section below).
A separate cohort of mice (n0100) was used to generate
“high-PPI” and “low-PPI” subjects as part of a large-scale
study. The animals underwent the same PPI screening as
described above. Four variables were calculated for each
animal: (1) average reactivity in no-stimulus (background
noise only) trials, (2) average reactivity in pulse-alone trials,
(3) average percent PPI across all five prepulse-pulse condi-
tions, and (4) the linear component of the downward sloping
reactivity curve expressed as a function of prepulse intensity
(+0, +4, +8, +12, +16, +20 decibel units above background)
obtained by linear regression—the calculation was based on
logarithmic-transformed (ln-transformed) reactivity scores.
Due to the larger size of the second cohort (N0100), we
decided a priori that 5 % (the highest and lowest 2.5 %, i.e.,
in effect the three highest and lowest subjects) extreme
subjects in any of the four critical variables should be
excluded before compiling the “high-PPI” (N023) and
“low-PPI” (N023) groups. This was carried out to avoid
inclusion of subjects would conventionally be considered as
outliers on statistical grounds and therefore not representa-
tive of the general population. Such trimming was consid-
ered less critical in the first cohort with a smaller sample size
(N023) because the top and bottom 2.5 % would only
amount to 0.57 subject at each extreme.
Next, the remaining animals were ranked according to
the two complementary PPI indexes (variables 3 and 4) and
subjected to a median-split accordingly to each variable.
Finally, only animals that received the same high–low clas-
sification by both variables were retained. This strategy of
segregation ensured that the division was robust and mini-
mized the potential distortion due to individual differences
in baseline reactivity (pulse-alone reaction) rather than PPI
expression (Csomor et al. 2006, 2008; Yee et al. 2005). The
final outcome yielded 23 “high-PPI” subjects and 23 “low-
PPI” subjects. Out of them, 15 and 13 subjects were ran-
domly selected for the present post-mortem study.
Post-mortem neurochemistry
Levels of dopamine (DA) and its metabolites (dihydroxy-
phenylacetic acid, DOPAC; homovanillic acid, HVA) were
determined using high performance liquid chromatography
(HPLC) according to procedures established before (Peleg-
Raibstein and Feldon 2006, 2008; Peleg-Raibstein et al.
2005; Bitanihirwe et al. 2010). High- and low-PPI subjects
were killed and dissected in random order. The brains were
extracted from the skull in toto within 1 min after decapita-
tion and immediately frozen on dry ice and then were stored
at −80 °C until dissection.
For dissection, the frozen brain was placed ventral side
up on an ice-chilled plate covered with filter paper and was
cut free-hand with an ultra-fine razor blade into in the
coronal plane into approximately 0.5- to 1-mm coronal
serial sections. Based on visible anatomical landmarks iden-
tifiable on the exposed coronal plane, five sections
corresponding to the anterior–posterior levels: [+2.3 to
+1.3], [+1.3 to +0.3], [−0.1 to −0.6], [−1.2 to −2.2], and
[−2.8 to −3.8] mm relative to bregma, were selected by
cross-reference with the Paxinos and Franklin’s (2001)
mouse brain atlas.
The chosen slices were collected and placed on an ice
cold dissection plate for the removal of discrete brain
regions, using a 1-mm micro-punch under visual guidance
for the caudate putamen (CPu), medial prefrontal cortex
(mPFC), nucleus accumbens (NAC), amygdala (AMY),
dorsal hippocampus proper (dHPC), and ventral hippocam-
pus proper (vHPC). Tissue punches from the left and right
hemispheres of each brain area of interest were combined,
weighed, and placed in 1.5-ml polypropylene microcentri-
fuge tubes containing ice-cold 300 μl 0.4 M HClO4 and
homogenized using ultrasound. After centrifugation at
10,000×g for 20 min at 4 °C, the clear supernatant layers
were removed into a 1-ml syringe and filtered through a 0.2-
μm nylon filter to separate the insoluble residue. This solu-
tion was immediately frozen and stored at −80 °C until
injection onto the HPLC system. For all brain regions, with
the exception of CPu and NAC, an aliquot of 50 μl was
injected in the HPLC system. Due to the much higher
concentration of dopamine in the CPu and NAC, only
20 μl was injected into the column.
Chromatographic conditions for detection of dopamine
and metabolites
A HPLC system coupled with an amperometric electro-
chemical detector (Decade II; Antec, Leyden, The Nether-
lands) was used to determine concentrations of dopamine
(DA), dihydroxyphenylacetic acid (DOPAC), and homova-
nillic acid (HVA). The samples were injected via a refriger-
ated autoinjector (ASI-100; Dionex, CA, USA) equipped
with a 100-μl injection loop. The samples were separated
on a reversed-phase column (125 mm×3 mm YMC column,
Nucleosil 120-3C 18; YMC Europe GmbH, Germany). An
HPLC pump (P680; Dionex) connected to a pulse damper
and a degasser was used to pump the mobile phase (see
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below) throughout the system. The working potential of the
electrochemical glassy carbon flow cell (VT-03; Antec,
Leyden, Netherlands) was +0.70 V versus an ISAAC refer-
ence electrode. A chromatography workstation (Chrome-
leon; Dionex, Olten, Switzerland) was used for data
acquisition and calculations. The mobile phase consisted
of 250 ml of HPLC-grade acetonitrile, 5 l of aqueous solu-
tion containing 0.27 mM sodium ethylenediammoniumte-
traacetate (disodium EDTA; C10H14N2O8Na2·2H2O),
0.43 mM triethylamine (C2H5)3N, 8 mM potassium chlo-
ride, and 0.925 mM octanesulfonic acid (C8H17O3SNa)
which acted as an ion pairing reagent. The pH was adjusted
to 2.95 by adding concentrated phosphoric acid. This was
pumped through the system at a flow rate of 0.4 ml/min. The
position and height of the peaks of the endogenous compo-
nents were compared with samples of external calibrating
standard solutions. Detection limits were at least approximate-
ly 0.2 nM of transmitter or metabolite per sample (between 20
to 50 μl per sample—see above). This implies that readings
roughly below three times the background noise levels would
be considered as below the detection limit and dropped from
data analyses to ensure detection reliability.
Statistical analysis
All data were analyzed by parametric analysis of variance
(ANOVA) with the appropriate design, including the
between-subject factor "baseline-PPI" corresponds to the
contrast between "high-PPI" and "low-PPI" and necessary
within-subjects factors (blocks, prepulse intensity, 5-min
bins, and amphetamine challenges). To better conform to
the normality and homoscedasticity assumptions of
ANOVA, logarithmic transformation (indicated as “ln-trans-
formed” in the text and figures) was applied to individual
average reactivity data in the prepulse inhibition experiment
[lne (reactivity score+e)−1] (see Csomor et al. 2008). A
statistical significance of p <0.05 was used. Effect size was
indexed by ηp
2. Data are presented as means±standard error
of the mean (SEM) in all figures. The analyses were per-
formed by SPSS version 18 (Chicago, IL, USA) running on
a Microsoft Windows 7™ operating system.
Results
Segregation of baseline PPI performance prior
to amphetamine treatment
The statistical outcomes of the respective ANOVAs in support
of the successful segregation of high- and low-PPI groups are
summarized in the table accompanying Fig. 1. As expected, the
separation of "high-PPI" and "low-PPI" individual (n07 each)
led to the predictable difference in%PPI (Fig. 1a). The presence
of a prepulse stimulus shortly preceding the startle-eliciting
pulse stimulus was effective in reducing the startle response
to the pulse stimulus in both groups, but this PPI effect was
stronger in the high-PPI groups (see Fig. 1b). The two groups
did not differ significantly in startle reactivity in trials which
only the pulse stimulus was presented (i.e., pulse-alone trials).
No difference in startle habituation was evident when the first
and last blocks of six pulse-alone trials were compared
(Fig. 1d), which is consistent with our previous studies in
C57BL/6 male mice (e.g., Bitanihirwe et al. 2011; Singer et
al. 2009; Singer and Yee 2012). The two groups, however,
differed significantly in their spontaneous activity recorded in
"no-stimulus" trials, which was stronger in the low-PPI group
(2.76±0.19) than the high-PPI group (2.16±0.19). When we
controlled for this non-specific difference, a clear group differ-
ence emerged between high- and low-PPI subjects in their
direct reaction to the prepulse stimuli—defined as reactivity
above that recorded in "no-stimulus" trials (Fig. 1c). The out-
come is consistent with previous studies showing that PPI
magnitude correlates with prepulse-elicited reaction in
C57BL/6 mice (Yee et al. 2004a, b; Yee and Feldon 2009).
Differential acute and sensitized response to amphetamine
between high- and low-PPI subjects
The three phases of the open field test of locomotor activity
—pre-injection baseline, saline, and amphetamine phases—
were separately analyzed.
Baseline phase Locomotor activity never differed between
high- and low-PPI groups in this phase. Habituation across
the two open field tests was evident, and within-session
habituation was more clearly seen in the first than the
second test (Fig. 2). A 2×2×3 (PPI baseline × tests × 5-
min bins) revealed a significant effect of tests [F(1,12)0
135.20; p<0.0001; ηp
200.92], bins [F(2,24)04.67; p<0.02;
ηp
200.28], and their interaction [F(2,24)05.04; p<0.02;
ηp
200.30]. Neither the main effect of PPI performance nor
its interactions achieved statistical significance.
The lack of a group difference in spontaneous open field
locomotor activity stood in contrast to the presence of a
baseline reactivity difference in the PPI experiment as
recorded in "no-stimulus" trials (see above). This suggested
that the two measures were likely unrelated. This is explic-
itly addressed by correlative analyses which revealed that
while individual variation in baseline open field activity
correlated significantly across the two tests [r0+0.64; p<
0.01; df012], neither of these measures was significantly
related to baseline reactivity in the PPI experiment [r0+0.14
to 0.02; p00.64 to 0.94; df012].
Saline phase Comparison of the saline phase between the
two tests again revealed long-term habituation. Within-
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session habituation was evident in low-PPI subjects in both
tests, but it was only apparent in high-PPI subjects in the
first session (Fig. 2). Instead of habituation, high-PPI sub-
jects even exhibited a tendency of sensitization during the
saline phase of the second test. It was also evident that low-
PPI subjects responded to the saline injection more strongly
than high-PPI subjects. These interpretations were sup-
ported by a 2×2×3 (PPI performance×open field×5-min
bins) split-plot ANOVA of distance moved, which revealed
a main effect of tests [F(1,12)066.88; p<0.0001; ηp
20
0.85], bins [F(2,24)03.52; p<0.05; ηp
200.23], tests by bins
interaction [F(2,24)06.17; p<0.007; ηp
200.34], and the
three-way interaction [F(2,24)03.51; p<0.05; ηp
200.23].
Post hoc pair-wise comparisons between high- and low-
PPI subjects indicated that high-PPI subjects were more
active than low-PPI subjects in the first and third bins of
test 1, and the first two bins of tests 2.
Amphetamine phase Motor activity was potentiated by am-
phetamine, and this effect was stronger following the second
injection, which constituted the behavioral sensitization ef-
fect. This effect was more pronounced in the low-PPI group
Fig. 1 Summary of the segregation between high-PPI and low-PPI
groups. Four sets of behavioral indices are presented here. a This graph
depicts %PPI as a function of increasing prepulse intensity (as decibel
units above background noise of 65 dB). Increasing prepulse intensity
resulted in stronger inhibition of the startle response to the pulse, with
the high-PPI mice consistently showing≈15 % more %PPI compared
with the low-PPI mice. b This graph depicts the reactivity scores (ln-
transformed) to the pulse stimulus in pulse-alone trials (i.e., prepulse
intensity00 dB above background) and prepulse-plus-pulse trials
across increasing prepulse higher intensity. The successive reduction
of the startle response with increasing prepulse intensity is indicative of
the prepulse inhibition effect, which was more pronounced (i.e., steep-
er reduction) in the high-PPI group compared with the low-PPI group,
leading to the significant group difference emerged from prepulse
intensity of +8 decibel units or higher. c This graph illustrates the
direct reaction (ln-transformed) to the prepulse stimulus with increas-
ing intensity obtained in prepulse-alone trials. §: The reactivity score is
normalized by subtraction from individual’s baseline spontaneous re-
action recorded in no-stimulus trials, and thus removing a significant
confounding effect between groups (see tabulated ANOVA outcomes
below). This is necessary for accurate evaluation at this lower range of
reactivity, which indicated that prepulse-elicited direct response was
also stronger in the high-PPI group relative to the low-PPI group from
prepulse intensity of +12 decibel units onwards. d This bar chart
compares the reaction to the pulse stimulus in the first and last block
of trials, each comprising only six pulse-alone trials. The lack of a clear
reduction from the first to the last block suggested habituation was
weak or absent in both high-PPI and low-PPI groups. Asterisks (*)
indicate significant between-group difference (p<0.05) revealed by
pair-wise post hoc comparisons using the pooled variance of the
overall ANOVA. The table below summarizes the design and outcomes
of the five separate ANOVAs. Significant effects, including indexation
of effect size by partial eta-squared (ηp
2), are highlighted by black
frames. All data depicted refer to group means±SEM
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both in terms of the magnitude of the potentiated response
and the rapidity of its onset (Fig. 2). In contrast, the behav-
ioral sensitization effect though evident was relatively weak
in the high-PPI group. Consistent with these interpretations,
a 2×2×24 (PPI baseline× tests×5-min bins) split-plot
ANOVA on distance moved yielded significant main effects
of tests [F(1,12)034.80; p<0.0001; ηp
200.74] and 5-min
bins [F(23,276)032.11; p<0.0001; ηp
200.73], and their
interaction [F(23,322)03.32; p<0.001; ηp
200.39]. The dif-
ferential response between high- and low-PPI groups across
the two tests was evident by the significant three-way inter-
action [F(23,322)01.75; p<0.05; ηp
200.18] and the nearly
significant PPI baseline by tests interaction [F(1,12)04.50;
p00.056; ηp
200.27]. Post hoc pair-wise comparison be-
tween high- and low-PPI subjects suggested that high-PPI
group showed a stronger response to the first amphetamine
challenge at bins 3–5 following injection. On the other hand,
low-PPI group showed a consistent elevated response to the
second amphetamine challenge at bins 2 to 20 (except at the
13th bin).
In addition, we estimated the bin at which the peak
activity response to amphetamine was recorded for each
animal (Fig. 3). Behavioral sensitization in the form of a
clear temporal facilitation was detected in the low-PPI group
but not in the high-PPI group. A 2×2 (PPI baseline×tests)
split-plot ANOVA of this variable yielded a highly signifi-
cant interaction [F(1,12)018.68; p<0.002; ηp
200.61], ac-
companied by a main effect of tests [F(1,12)08.5; p<0.02;
ηp
200.41]. Post hoc comparisons further revealed that low-
PPI group was slower to reach peak response following the
first amphetamine challenge but quicker in response to the
second challenge [both p’s<0.05], in agreement with the
analysis based on distance moved (see Fig. 2).
Post-mortem neurochemistry
Among the brain areas examined, the high- and low-PPI
groups were readily differentiated by all dopaminergic
markers in the mPFC (Table 1). The mPFC DA levels of
low-PPI mice were nearly 5-fold of that observed in high-
Fig. 2 The locomotor activity response to an amphetamine injection. a
The locomotor activity levels in response to the first challenge of
systemic amphetamine (2.5 mg/kg, i.p.) did not grossly differ between
the high- and low-PPI groups. Their average as well as peak response
was comparable, although the onset of the response appeared to be
slower and more protracted in the low-PPI mice. b The response to the
second challenge of amphetamine at the same dose yielded a stronger
stimulation of locomotor activity compared to the first challenge, thus
constituting the amphetamine sensitization effect. However, the low-
PPI group now exhibited a consistently stronger response compared
with the high-PPI group. Data presented are total distance moved (m)
across successive 5-min bins (mean±SEM) in baseline (15 min), saline
(15 min), and amphetamine (120 min) phases of the open field test.
Sample sizes were seven per group. Asterisk (*) indicates significant
group difference at p <0.05 based on post hoc comparisons using the
pooled variance of the overall ANOVA
Fig. 3 Time to peak motor activity in response to amphetamine. The
bin at which the peak activity score was achieved following amphet-
amine challenges (first versus second injection separated by 24 h) was
calculated for each individual animal. While this measure hardly dif-
ferentiated the first and second response to amphetamine for the high-
PPI subjects, the behavioral sensitization observed in the low-PPI
subjects was clearly associated with an earlier peak response. Data
presented mean±SEM (N07 per group). Asterisk (*) indicates signif-
icant group difference at p <0.05 based on post hoc comparisons using
the pooled variance of the overall ANOVA
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PPI subjects [F(1,24)018.04; p<0.0005; ηp
200.43]. This
was accompanied by similar increases in dopamine metab-
olites: dihydroxyphenylacetic acid {DOPAC, nearly 4-fold
[F(1,24)036.34; p<0.0001; ηp
200.60]} and homovanillic
acid {HVA, nearly 2-fold [F(1,24)017.30; p<0.0001;
ηp
200.42]}. The HVA/DA ratio in mPFC of low-PPI sub-
jects was significantly lower than that of high-PPI subjects
[F(1,24)08.82; p<0.01; ηp
200.27], although the other met-
abolic ratio (DOPAC/DA) did not differ between groups.
Nucleus accumbens (NAC) DA levels were also signifi-
cantly higher (+50 %) in the low-PPI mice relative to high-
PPI mice [F(1,25)07.22; p<0.05; ηp
200.22]. This differ-
ence was weaker in magnitude than in the mPFC and was
not accompanied by any significant changes in DOPAC or
HVA. As summarized in Table 1, no significant differences
were detected in other brain regions.
Discussion
The present study tested the hypothesis that a random se-
lection of adult male wild-type C57BL/6 mice stratified into
high- and low-PPI performance groups might differ mark-
edly in the development of behavioral sensitization in re-
sponse to amphetamine in association with significant
divergence in the dopamine system. It is conceptually linked
to previous suggestions that baseline PPI could critically
decide the magnitude and/or direction of response to anti-
psychotic drugs in healthy human volunteers (Csomor et al.
2008; Swerdlow et al. 2003; Vollenweider et al. 2006) and
animal subjects (Hadamitzky et al. 2007). Here, we extend-
ed this important insight to mice by demonstrating that
baseline PPI can also predict psychotomimetic drug action,
importantly beyond PPI performance itself—namely, the
sensitized motor response to amphetamine as well as select-
ed dopaminergic markers confined to specific structures
within the mesolimbic dopamine system. Thus, individual
differences in sensorimotor gating as indexed by the cross-
species PPI paradigm might provide useful insights into the
functional state of the dopaminergic system, including its
capacity for neuroadaptation implicated in the development
of sensitization and, according to Laruelle’s (2000) hypoth-
esis, perhaps symptom genesis in schizophrenia.
Here, although the distinction between low- and high-PPI
subjects was most readily distinguishable by their sensitized
response to amphetamine, detectable divergence was al-
ready noticeable in their first acute response to amphet-
amine. Critical to the interpretation of the former is that
the observed impacts of the low-high PPI segregation be-
tween the two occasions appeared opposite in direction (see
Fig. 2). Thus, low-PPI subjects were somewhat less respon-
sive to the first amphetamine challenge, yet they showed a
substantially stronger response upon the second challenge
348 Psychopharmacology (2013) 225:341–352
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when compared to the high-PPI subjects. Hence, the latter
cannot be considered as a scaling effect of the former.
Conversely, the weaker sensitization effect seen in the
high-PPI group cannot be merely attributed to a shift in
the dose–response relationship relative to the initial amphet-
amine challenge.
Consistent with the known neural bases underlying the
acute and sensitized response to amphetamine (Kauer and
Malenka 2007; Pierce and Kalivas 1997), post-mortem quan-
tification of dopamine and its metabolites in the drug naïve
cohort revealed significant divergences primarily in the mes-
ocorticolimbic dopamine system centering on dopamine-rich
mPFC and NAC (see Table 1). The nigrostriatal dopamine
measures taken from caudate putamen (CPu), in contrast,
failed to differentiate between high- and low-PPI subjects.
Notably, the overall neurochemical values obtained here are
in general agreement with other similar studies in mice (e.g.,
Hadfield and Milio 1988, 1989), suggesting that the neuro-
chemical divergences observed correspond well to deviations
from the normal population means. One exception is the
contrast between dorsal and ventral hippocampus dopamine
content here. Statistical comparison revealed that dopamine
content was significantly higher in the dorsal hippocampus [F
(1,23)05.84, p00.024]. This is opposite to the gradient com-
monly associated with rats (e.g., Verney et al. 1985; Peleg-
Raibstein et al. 2006a; Peleg-Raibstein and Feldon 2008),
although we have obtained a similar, yet non-significant, trend
before in C57BL/6 mice (Bitanihirwe et al. 2010). Hence, the
possibility of a species difference might be likely, which may
not be surprising given that a dorso-ventral gradient in hippo-
campal dopamine content is not consistent across rat strains
(e.g., Rüedi-Bettschen et al. 2006). This highlights the impor-
tance of replicating our current findings in other species and
strains.
The presumably pre-existing dopaminergic differences
specific to the mPFC and NAC, however, did not translate
into baseline difference in spontaneous locomotor activity.
This is somewhat unexpected given that stimulation or
blockade of dopamine transmission within nucleus accum-
bens affects spontaneous locomotor activity (e.g., see Ike-
moto and Panksepp 1999), but it should be emphasized that
no such extrinsic manipulations was employed here. Any
neurochemical divergence revealed here between high-PPI
and low-PPI subjects should not be interpreted as the equiv-
alence of acute pharmacological blockade and stimulation of
dopamine transmission in normal mice, respectively. The
observed dopaminergic divergences here were not by design
but emerged as correlates of an a priori behavioral segrega-
tion, so they cannot be equated with local manipulations.
Indeed, evaluation of additional neural correlates in terms of
brain neurochemistry, physiology, or anatomy is warranted
in order to ascertain the full neurobiological significance of
the segregation based on PPI performance.
Thus, the lack of a difference in spontaneous activity here
does not contradict with available evidence that direct inter-
vention of mesocorticolimbic dopamine targeting the NAC
(Ikemoto and Panksepp 1999) or mPFC (e.g., Bast et al. 2002)
can significantly modify spontaneous activity without a con-
comitant amphetamine challenge. One possibility is that a
sustained shift of baseline dopaminergic differences over time
might lead to functional compensation, e.g., a down-
regulation of receptor density or sensitivity. The amphetamine
sensitization regime effectively unmasked the functional rele-
vance of the baseline dopaminergic divergence. Similar com-
pensatory mechanisms might be responsible for the apparent
lack of an effect on spontaneous activity by selective lesions
of either mPFC or NAC until the animals were challenged by
amphetamine (Lacroix et al. 2000; Tai et al. 1991; Yee 2000).
Alternatively, dopamine tissue levels might be a poor correlate
of synaptic dopamine transmission, and more direct measures
of post-synaptic activation might not yield a difference in the
absence of amphetamine challenge.
In this respect, it is worth noting that the first evidence of
divergent activity levels emerged in response to the saline
injection in the two open field tests. Despite a decrease in
overall activity from the first to the second test, probably
indicative of habituation to the open field, low-PPI but not
high-PPI mice clearly showed an elevation in activity fol-
lowing saline injection, leading to a divergence in activity
levels between them (see Fig. 2). Given that this was con-
sistently observed on both test days, the behavior of the low-
PPI mice is unlikely the result of conditioned response to the
injection cues, which would only be expected to be possible
in the second test.
This differential response to saline injection might reflect
a stronger dopamine-mediated stress response in the low-
PPI subjects, perhaps via mPFC connection to the hypothal-
amus (Vermetten and Bremner 2002; Weiss 2007). Hence,
the regulation of locomotor activity by basal mesocortico-
limbic dopamine system might indeed be more readily
revealed when the system is activated or engaged by rele-
vant external stimulus. Novelty or mild stress such as han-
dling and injection is sufficient to stimulate dopamine efflux
in the prefrontal cortex (Feenstra 2000; Feenstra et al. 2000;
Peleg-Raibstein et al. 2005), which might be linked to the
transient elevation of motor activation induced by the saline
injection seen only in the low-PPI mice at the end of the
habituation phase—an effect that was more akin to dishabi-
tuation rather than motor stimulation (to supra-normal lev-
els) per se. However, it is perplexing as to why the same
low-PPI mice did not exhibit at the same time a stronger
reaction to the first acute dose of amphetamine. Instead,
high-PPI mice were quicker in responding to the drug,
though the magnitude of their reaction was not significantly
stronger, considering the area under the curves during the
amphetamine phase in Fig. 2a.
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Sensitization is associated with PPI deficiency
The present finding is also in line with previous studies in
healthy human subjects and in rats which reported that
dopaminergic manipulations modify prepulse effects on
startle magnitude in a manner that depends on basal levels
of PPI (Depoortere et al. 1997; Swerdlow et al. 2003, 2006;
Talledo et al. 2009), thus affecting only subjects with low
PPI levels and with no effect on high-PPI subjects (e.g.,
Vollenweider et al. 2006; Hadamitzky et al. 2007). Reports
that low levels of PPI in healthy subjects are correlated with
psychosis proneness and schizotypy (e.g., Swerdlow et al.
1995) also indirectly suggest that subjects with low PPI
might have a higher basal dopaminergic tone. The observa-
tion that the effects of amphetamine on PPI are inversely
related to baseline levels of PPI is not unique. “Rate depen-
dency” has been proposed as a possible mechanism under-
lying some of the therapeutic effects of stimulants in
attention deficit hyperactivity disorder (Lyon and Robbins
1975). Thus, subjects with relatively high dopaminergic
tone are disrupted behaviorally by amphetamine, while
those with relatively low dopaminergic tone might have
their performance enhanced.
PPI has been shown to be affected by treatments that alter
dopaminergic transmission such as direct and indirect dopa-
mine agonists; these effects can be blocked by administra-
tion of antipsychotic drugs (for review, see Geyer et al.
2001). There is some evidence that the effects of dopamine
manipulations involve the nucleus accumbens and its asso-
ciated neural circuits including afferents originating from
the mPFC. Neurochemical analysis in the drug naïve cohort
of high- and low-PPI mice revealed that segregation by
baseline PPI performance also predicted a difference in
intrinsic (i.e., not drug-induced) dopaminergic markers in
the relevant brain regions. This raises the possibility that
higher dopamine levels in the mPFC and nucleus accum-
bens predispose the development of sensitization to stimu-
lant drugs. Further validation of such a link by in vivo
microdialysis directly contrasting dopamine release during
baseline and following amphetamine challenge in the same
animals would be critical, and the present study points to the
mPFC as the most promising target to be investigated first
(cf., Yee 2000). Such in vivo within-subject studies would
be necessary to delineate the neural substrates underlying
the behavioral and neurochemical differences between low-
and high-PPI subjects.
Conclusion: the predictive value of PPI
As the first psychopharmacological characterization of a
behavioral segregation solely with respect to a single schizo-
phrenia endophenotype (PPI expression) within a genetical-
ly homogeneous population inbred mice, we showed that
PPI expression is sufficient to predict a specific form of
dopamine plasticity—the sensitized motor response to am-
phetamine. This admittedly is based on a correlative ap-
proach, which is certainly insufficient by itself to support a
causative link. Yet, our emphasis on a single mouse strain
here suffered less confounding differences than models
based on inter-strains comparison, such as that between
DBA/2 and C57BL/6 mice (Flood et al. 2011; Singer et al.
2009), or the alternative approach of selective breeding
pioneered by Hadamitzky et al. (2007), which produced
separate rat lines with divergent PPI performance as herita-
ble traits. In contrast, the use of inbred mice here minimizes
genetic variation and emphasizes instead subtle environ-
mental influences. These multiple lines of research all bear
translational significance to human data demonstrating that
basal PPI levels in healthy volunteers is also a critical
determinant of their sensory gating response under the in-
fluence of antipsychotic drugs (e.g., Vollenweider et al.
2006; Csomor et al. 2008). Hence, PPI might serve as an
effective screen for the early detection of individuals with
increased environmental as well as genetic risks for psy-
chotic proneness linked to dopamine sensitivity.
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